Cargando…
Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators
Loxoprofen (LOX) is a non-selective cyclooxygenase inhibitor that is widely used for the treatment of pain and inflammation caused by chronic and transitory conditions. Its alcoholic metabolites are formed by carbonyl reductase (CR) and they consist of trans-LOX, which is active, and cis-LOX, which...
Autores principales: | Paudel, Sanjita, Shrestha, Aarajana, Cho, Piljoung, Shrestha, Riya, Kim, Younah, Lee, Taeho, Kim, Ju-Hyun, Jeong, Tae Cheon, Lee, Eung-Seok, Lee, Sangkyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781309/ https://www.ncbi.nlm.nih.gov/pubmed/31527544 http://dx.doi.org/10.3390/pharmaceutics11090479 |
Ejemplares similares
-
Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation
por: Shrestha, Riya, et al.
Publicado: (2018) -
Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol
por: Cho, Pil Joung, et al.
Publicado: (2018) -
Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα
por: Jeon, Kyung-Hwa, et al.
Publicado: (2021) -
Discovery and Validation of a Novel Step Catalyzed by OsF3H in the Flavonoid Biosynthesis Pathway
por: Jan, Rahmatullah, et al.
Publicado: (2021) -
Pharmacokinetics of loxoprofen in a self-administered overdose in a Japanese patient admitted to hospital
por: Adachi, Koichiro, et al.
Publicado: (2021)